Healthcare


Drug Discovery Technology Alert. Molecules To Treat Genetic Diseases and HIV; Silver Nanoparticles Immobilized on Nanoscale Silicate for Effective Wound Healing; Ready-To-Use Glucagon Formulation Holds Potential for Hypoglycemia Treatment

Share this:

This issue profiles molecules to treat genetic diseases and HIV, silver nanoparticles immobilized on nanoscale silicate for effective wound healing, and ready-to-use glucagon formulation that holds potential for hypoglycemia treatment.

Click headings to expand and collapse Published: 8 Jun 2012

Tools

Features of this research

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..